A Phase 1 Study of KITE-753 or KITE-363 in Patients with Relapsed/Refractory B-cell Lymphoma: Initial Safety and Preliminary Efficacy of KITE-753 and Updated Results of KITE-363

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Saurabh Dahiya, Matthew L. Ulrickson, Jean Adel Yared, Patrick Michael Reagan, Timothy J. Voorhees, Ran Reshef, Cameron John Turtle, Lizamarie Bachier‐Rodriguez, Marie José Kersten, Max S. Topp, Gary Lee Simmons, Robin Sanderson
+9 more Loretta J. Nastoupil, Andre Scott Jung, Enrique Granados, Jinghui Dong, Joshua Winters, Rhine R. Shen, Justyna E. Kanska, Myrna Rita Nahas, Sairah Ahmed
DOI: 10.1016/j.jtct.2025.12.097
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment T-cell and B-cell Immunology

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S64–S65
Publication date
1 February 2026
Language
EN